-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Breast cancer (BC) is still the leading cause of female cancer and the second most common cause of death worldwide
.
In recent years, next-generation sequencing (NGS) has played a key role in understanding and identifying altered genetic pathways involved in the development and progression of cancer
Breast cancer (BC) is still the leading cause of female cancer and the second most common cause of death worldwide
A total of 78 Arab women with breast cancer were included in this analysis, using NGS containing 46 genes [CMS46] or 50 genes [CMS50] for somatic mutation detection
.
The median age at diagnosis was 52.
A total of 78 Arab women with breast cancer were included in this analysis, using NGS containing 46 genes [CMS46] or 50 genes [CMS50] for somatic mutation detection
Clinical features
Clinical featuresThere were 18 (23.
1%) and 60 (76.
9%) patients tested by NGS CMS46 and CMS50, respectively
.
Common somatic mutations are: TP53, 23.
There were 18 (23.
Common mutant genes
Common mutant genesIn summary, the study clarified the frequency of somatic mutations in Arab women with breast cancer, indicating a certain difference from the Western population
.
These data need to be more large-scale epidemiological study to assess such mutations in the prognosis and personalized management role in
In summary, the study clarified the frequency of somatic mutations in Arab women with breast cancer, indicating a certain difference from the Western population
Original source:
H UMAID O.